INTRODUCTION
Retinitis pigmentosa (RP; MIM] 268000) constitutes a group of progressive degenerative diseases of the retina. With a combined incidence of 1:3,500, RP is the most common inherited retinopathy, which is associated with night-blindness, gradual reduction of peripheral visual fields, and eventually loss of central vision [Heckenlively, 1988; Kennan et al., 2005] . To date, 181 retinopathy loci have been mapped and 129 genes identified [Rivolta et al., 2002] (RetNet website; www.sph.uth.tmc.edu/ Retnet). In general, RP-associated genes encode components of the phototransduction cascade, retinoid metabolism, photoreceptor structural proteins, intracellular transport proteins, splicing factors, and transcription factors [Bessant et al., 2001; Kennan et al., 2005; Rattner et al., 1999] . Neural retina leucine zipper (NRL; MIM] 162080, cone-rod homeobox (CRX; MIM] 602225), nuclear receptor subfamily 2 group E member 3 (NR2E3; MIM] 604485), and Tubby-like protein 1 (TULP1; MIM] 602280) are among the known and/or putative transcription factors, mutations in which cause RP [Banerjee et al., 1998; Bessant et al., 1999; Boggon et al., 1999; Hagstrom et al., 1998; Haider et al., 2000; Nishiguchi et al., 2004; Sohocki et al., 1998 ]. NRL, a bZIP transcription factor of the Maf-subfamily, is a phosphorylated protein that is specifically expressed in rod photoreceptors and pineal gland, but not in cones or other cell types [Akimoto et al., 2006; Swain et al., 2001] . Deletion of Nrl (Nrl À/À ) in mouse results in the retina with no rods but a concomitant increase of cone photoreceptors derived from cells fated to be rods [Akimoto et al., 2006; Mears et al., 2001] . NRL is shown to bind to a cis-regulatory sequence (Nrl response element, NRE) in the rhodopsin promoter and enhance its activity in cultured cells alone or together with CRX, NR2E3, and other proteins [Chen et al., 1997; Cheng et al., 2004; Lerner et al., 2001; Mitton et al., 2000 Mitton et al., , 2003 Pittler et al., 2004; Rehemtulla et al., 1996] . A number of downstream target genes of NRL have been identified by combining microarray analysis with chromatin immunoprecipitation studies [Yoshida et al., 2004; Yu et al., 2004] . These findings suggest an essential role of NRL in normal rod photoreceptor differentiation and functional maintenance. A mutation in codon 50 (Serine to Threonine) of NRL was first associated with autosomal dominant RP (ADRP), and this change was suggested to be a hypermorph [Bessant et al., 1999] . NRL mutation screens have now revealed 14 missense and three frameshift sequence variations in patients with retinal disease ( Fig. 1 ; Table 1 ) [Acar et al., 2003; Bessant et al., 1999; DeAngelis et al., 2002; Martinez-Gimeno et al., 2001; Nishiguchi et al., 2004; Wright et al., 2004; Ziviello et al., 2005] [Nishiguchi et al., 2004; Ziviello et al., 2005] . Due to a very low occurrence of sequence changes in the NRL gene [Acar et al., 2003] , it is possible that some sequence variations predispose certain individuals to photoreceptor disease.
We initiated this study for a comprehensive biochemical evaluation of all detected sequence changes in NRL, with a goal to obtain insights into their contribution to human retinal disease and to permit better understanding of structure-function relationships. Previously, we had described the effect of p.S50T, p.P51S, and p.L160P mutations in NRL on rhodopsin promoter activity in cultured cells [Bessant et al., 1999; Nishiguchi et al., 2004] . Here, we have determined the effects of all 17 reported sequence changes on NRL's phosphorylation, nuclear localization, DNA-binding ability, and transcriptional activation. Our studies demonstrate the role of phosphorylation and validate a critical function of p.S50 and p.P51 residues in modulating NRL's transcriptional activity. Our data also suggest possible contributions of sequence changes in NRL on the pathogenesis of retinal disease.
MATERIALS AND METHODS Cell Culture and Transfection
COS-1 and HEK293 cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and transfected using FuGENE 6 (Roche Applied Science, Indianapolis, IN), at 80% confluency, with plasmid DNA, as previously described [Nishiguchi et al., 2004] .
Plasmid Construction and Mutagenesis
The wild-type (WT) human NRL cDNA (GenBank] NM_006177.2) was subcloned at the EcoRI-NotI sites in the pcDNA4 His/Max C vector (Invitrogen, Carlsbad, CA). The QuickChange XL site-directed mutagenesis kit (Stratagene, La Jolla, CA) was used, as described [Nishiguchi et al., 2004] , to generate all mutants from the NRL expression construct. All constructs were sequence-verified before use.
Immunoblot Analysis
Transfected COS-1 whole cell extracts were solubilized in 2 Â SDS sample buffer by heating to 1001C for 5 min and separated by 15% SDS-PAGE. Proteins were transferred to nitrocellulose by electroblotting, and immunoblot analysis was performed using a mouse monoclonal anti-Xpress antibody (Invitrogen) according to standard protocols [Ausubel et al., 1989] .
P Metabolic Labeling and Immunoprecipitation (IP)
Transfected COS-1 cells were metabolically labeled using 0.5 mCi/ml [g À32 P]ATP (GE Healthcare, Piscataway, NJ) as described [Ausubel et al., 1989] . After 1 hr, labeled cells were harvested in PBS containing 1 Â protease inhibitors, and sonicated. After cell extracts were preabsorbed with Protein-G agarose beads (Invitrogen), the cell extracts were incubated with antiXpress antibody and Protein-G agarose beads overnight at 41C with gentle shaking. The beads were washed with PBS containing 1% Triton X-100. The proteins were suspended in 2 Â SDS sample buffer and then analyzed by SDS-PAGE.
Phosphatase Treatment
Transfected COS-1 cells were harvested with phosphatase buffer containing 0.1 mM phenylmethanesulphonylfluoride (PMSF) and 1 Â complete proteinase inhibitor (Roche Applied Science), and treated for 1 hr at 301C with 80 units of l-phosphatase (New England Biolabs, Beverly, MA). The reaction was terminated by heating to 1001C for 5 min in 5 Â SDS sample buffer, and the samples were subjected to SDS-PAGE.
Immunocytochemistry
Transfected COS-1 cells were washed with PBS, fixed using 4% paraformaldehyde/PBS for 10 min, and washed again in PBS. Cells were permeabilized using 0.05% Triton X-100/PBS for 10 min. After washing, a 5% bovine serum albumin (BSA)/PBS solution was applied and the cells were blocked for 30 min. The cells were incubated for 1 hr with an anti-Xpress antibody (1:400 dilution) in 1% BSA/PBS, and with a secondary anti-mouse immunoglobulin G (IgG) Alexa fluor 488 (Molecular Probes, Eugene, OR) (1:400 dilution). Nuclei were counterstained with bisbenzimide, and cells were examined by fluorescent microscopy.
Electrophoretic Mobility Shift Assays (EMSA)
Gel shift assays were performed essentially as described [Rehemtulla et al., 1996] , with minor modifications. Nuclear extracts from transfected COS-1 cells were prepared using a commercial kit (Active motif, Carlsbad, CA), and expression of mutant NRL protein was normalized by immunoblot analysis. Nuclear extracts were preincubated for 30 min on ice in binding buffer containing 20 mM HEPES (pH 7.9), 1 mM EDTA, 50 mM NaCl, 1 mM dithiothreitol (DTT), 10% glycerol), 2.5 mg/ml poly(dI-dC). Radiolabeled DNA probes containing the rhodopsin-NRE site (NRE-F 5 0 -CTCCGAGGTGCTGATTCAGCCGGG A-3 0 ; NRE-R 5 0 -TCCCGGCTGAATCAGCACCTCGGAG-3 0 ) were added and extracts were incubated another 30 min at room temperature. The nonspecific oligonucleotides were NS-F 5 0 -GAG GGAGATATGCTTCATAAGGGCT-3 0 ; and NS-R 5 0 -AGCCCT TATGAAGCATATCTCCCTC-3 0 . DNA-protein complexes were analyzed on 4% nondenaturing polyacrylamide gels in 0.5 Â TBE.
Luciferase Assays
The luciferase reporter experiments were performed using HEK293 cells, and contained pGL2 with the bovine rhodopsin promoter driving a luciferase cDNA sequence (pBR130-luc), and expression constructs carrying the CRX cDNA (pcDNA4-CRX) and/or NR2E3 cDNA (pcDNA4-NR2E3), as described [Bessant et al., 1999; Nishiguchi et al., 2004] , with minor modifications. Increasing amounts (0.01, 0.03, and 0.09, 0.3 mg) of a NRL expression construct containing either WT or NRL mutant/variant was also cotransfected with pBR130-luc (0.3 mg per well), and pcDNA4-CRX and/or pcDNA4-NR2E3 (0.5 mg per well), as indicated for individual experiments. Empty pcDNA4 expression vector and cytomegalovirus-b-gal (0.1 mg per well) were included to normalize for the amount of transfected DNA and transfection efficiency, respectively. The reactions were repeated in triplicate at least three times except for earlier published mutants (p.S50T, p.P51S, p.L160P) [Bessant et al., 1999; Nishiguchi et al., 2004] .
RESULTS

Evolutionary Conservation of NRL Variants Identi¢ed in Retinopathy Patients
Evolutionary conservation of amino acid residues can provide significant insights into NRL function. NRL orthologs have been identified in many vertebrates with the exception of chicken [Coolen et al., 2005; Whitaker and Knox, 2004] . To date, 17 mutations and/or variations in the NRL gene have been detected [Bessant et al., 1999; DeAngelis et al., 2002; Martinez-Gimeno et al., 2001; Nishiguchi et al., 2004; Wright et al., 2004; Ziviello et al., 2005] ; these include 14 missense and three frameshift mutations (Fig. 1A) . All changes have been identified in 12 amino acids; three of these (p.S50, p.P51, p.L160) show more than one alteration. Five (p.S50, p.P51, p.A76, p.L160, and p.R218) of the 12 residues are conserved in all known orthologs of NRL from human to fugu (Fig. 1B) . Residues p.P67 and p.L75 are conserved in all orthologs, except zebrafish and frog, respectively (Fig. 1B) .
E¡ect of NRL Mutations/Variants on Protein Stability and Phosphorylation Status
In a previous study, NRL isoforms from human retina extract showed a pattern similar to that of transfected COS-1 cells or HEK293 cells (data not shown), suggesting that modifications of NRL are congruous among retina and these cell types. We therefore expressed WT and mutant NRL proteins in COS-1 cells to examine their effect on NRL stability and phosphorylation status. In contrast with at least six 30-35-kDa isoforms (including a 4-kDa Xpress epitope) of WT-NRL, all p.S50 and p.P51 mutants showed significant reduction of isoforms, with the appearance of a major 30-kDa band ( Fig. 2A) . The p.P67S, p.H125Q, and p.S225N proteins displayed patterns equivalent to that of WT-NRL, suggesting that these changes do not affect protein stability or phosphorylation ( Fig. 2A) . Mutants p.E63K, p.A76V, p.G122E, and p.L160P contained a different isoform pattern. The p.E63K band sizes were in the WT range, while that of p.L160P were of higher molecular mass. The p.A76V and p.G122E mutants were each missing the highest molecular mass band. The p.L235F protein migrated slightly below WT, but had no change in pattern. The number of isoforms in the p.L160fs and p.R218fs mutants were decreased by three and migrated at lower molecular mass. The p.L75fs mutant could not be detected, perhaps due to lower levels or unstable protein (data not shown). WT and mutant NRL constructs were transfected into human Y79 retinoblastoma cells as well. However, transfected NRL isoforms (carrying Xpress tag) could not be detected by immunoblot analysis because of low transfection efficiency (data not shown).
To directly test NRL phosphorylation, we performed metabolic labeling using [g À32 P]ATP and immunoprecipitation using antiXpress antibody. WT, p.S50T and p.P51S mutants were phosphorylated, with the mutant proteins showing only the lower isoform(s) (Fig. 2B) . Phosphatase treatment of the WT-NRLtransfected COS-1 cell extracts demonstrated a reduction in NRL isoforms, while the treated mutant proteins migrated slightly below the untreated (Fig. 2C) . This is consistent with previous studies showing a reduction in NRL isoforms upon phosphatase treatment of human and bovine retina extracts ].
E¡ect of NRL Mutations/Variants on Nuclear Localization
We then examined the subcellular distribution of mutant NRL proteins in COS-1 cells. All except two of the NRL mutant proteins (p.L75fs, p.L160fs) localized to the nucleus (Fig. 3) . Both of these mutations would be predicted to lose their bZIP domain and mislocalized to the cytoplasm. The p.L75fs mutant was essentially undetectable at exposure times equivalent to the other samples (Fig. 3) . At higher exposure, p.L75fs had very weak expression in a pattern similar to p.L160fs (data not shown).
E¡ect of NRL Mutations/Variants on DNA Binding
We previously showed that NRL is bound to NRE in the rhodopsin promoter (rhodopsin-NRE) [Rehemtulla et al., 1996] . We confirmed that COS-1-transfected NRL protein could also bind to the rhodopsin-NRE (Fig. 4A) . The intensity of the shifted bands was dramatically decreased by unlabeled rhodopsin-NRE in a concentration dependent manner; however, no change in intensity was detected with the nonspecific (NS) control oligonucleotide, and in fact the NS probe reduced the NS oligonucleotide shifts (Fig. 4A) p.L160fs, and p.R218fs bound to the rhodopsin-NRE (Fig. 4B) . The p.A76V alteration appeared to have lower than WT binding.
E¡ect of NRL Mutations/Variants onTransactivation of Rhodopsin Promoter
We tested the effect of mutations in NRL on their ability to transactivate luciferase reporter activity driven by the bovine rhodopsin promoter in the presence of CRX, as described [Rehemtulla et al., 1996] . All p.S50 and p.P51 mutants showed a statistically significant increase (analysis of variance [ANOVA] with a post hoc test; Po0.05) in transactivating the rhodopsin promoter when compared to WT-NRL at three of the four DNA concentrations tested (Fig. 5A) . The p.P67S, p.A76V, and p.G122E alterations had no change from WT, while p.H125Q gave inconsistent results being significantly higher than WT using 0.03 or 0.09 mg DNA and lower with 0.3 mg NRL DNA (Fig. 5B) . Mutations exhibiting lower than WT transactivation were: p.E63K, p.L160P, p.L160fs, p.R218fs, and p.S225N (Po0.05, in at least three of four DNA concentrations tested; Fig. 5C and D) . The p.L235F was significantly lower than WT at only two DNA concentrations (0.01 and 0.3 mg; Fig. 5C ).
We then examined whether mutant NRL proteins demonstrate altered transactivation of the rhodopsin promoter in the presence of NR2E3, which also acts as coactivator of rod genes with NRL and/or CRX . The p.S50T exhibited enhanced activation of the rhodopsin promoter when cotransfected with NR2E3 and/or CRX ( Fig. 6A and B) . The p.P67V and p.A76V did not show significant differences from WT in both experiments, whereas p.G122E and p.H125Q showed higher activities than WT when both NR2E3 and CRX were present (Po0.05, in at least three of four DNA concentrations tested; Fig. 6B ). The p.S50T and p.P51S mutants activated the rhodopsin promoter at higher levels than WT in the absence of CRX and NR2E3 and did not affect NRL's interaction with CRX or NR2E3, as revealed by co-IP experiments (data not shown).
DISCUSSION
Diseases associated with mutations in transcription factors can result from altered protein expression, stability, or function. Transient modulation of protein function can occur through posttranslational modification of proteins, such as phosphorylation, acetylation, ubiquitination, and/or sumoylation [Freiman and Tjian, 2003; Yang, 2005] . NRL has several predicted phosphorylation sites (18 serine, nine threonine, and seven tyrosine residues) and two sumoylation sites (Lys-20 and -24; -c-K-X-E-, where c is a hydrophobic residue) [Falquet et al., 2002; Puntervoll et al., 2003] . The six currently known p.S50 and p.P51 NRL mutations lead to ADRP in patients [Bessant et al., 1999; DeAngelis et al., 2002; Martinez-Gimeno et al., 2001; Nishiguchi et al., 2004] . All of these changes consistently display increased NRL-mediated transactivation of the rhodopsin promoter and a loss of NRL isoforms that is consistent with decreased NRL phosphorylation. Hence, NRL's activity appears to be altered by phosphorylation status. The p.S50 and p.P51 residues are located within NRL's minimal transactivation domain (MTD), which is important for the interaction of NRL with TATA-binding protein (TBP) . We hypothesize that phosphorylation status affects NRL's ability to bind TBP and other components of the general transcription machinery. Consistent with this, two serine residues (Ser-14 and -65) in the transactivation domain of the L-Maf protein (Ser-65 corresponds with Ser-50 in NRL), are shown to be important phosphorylation sites for extracellular-signal regulated kinase in vitro, and the p.S14A and p.S65A mutant L-Maf showed higher levels of reporter activity than WT protein [Ochi et al., 2003 ]. It appears that higher molecular mass isoforms of NRL have additional phosphorylated residues and exhibit lesser transcriptional activation of the rhodopsin promoter. Interestingly, NRL isoforms of higher molecular mass are detected in early developmental stages of mouse retina . These isoforms may interact with as yet undiscovered proteins and regulate the expression of different target genes. 
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Origin Origin FIGURE 4. E¡ect of NRL mutations on binding to rhodopsin-NRE. A: EMSA using the [ 32 P]-labeled NRE was incubated withWT NRL containing COS-1 nuclear extracts. DNA-NRL complex formation is sequence speci¢c for double-stranded DNA, as demonstrated by the competition with unlabeled rhodopsin-NRE oligonucleotide (1^50 Â) and using the nonspeci¢c (NS) oligonucleotide (50 Â).The thick arrow shows the position of a speci¢c DNA-protein binding complex between NRL and rhodopsin-NRE.Thin arrows indicate nonspeci¢c oligonucleotide shifts. B: Binding of mutant NRL proteins to rhodopsin-NRE.The extracts were ¢rst equalized toWT NRL by immunoblot analysis, and precleared with NS oligonucleotide (50 Â), prior to EMSA.
In mature rods, higher NRL transcription activity (and less phosphorylated isoforms) would probably be required to maintain high level expression of rod phototransduction genes, such as rhodopsin.
To further investigate the role of phosphorylation, we generated NRL mutants with individual and plural serine and threonine residues 38, 41, 45, 46, 50, 54, 91 , and 117, Thr-42 and 52) changed to alanine, and examined their effects on protein isoforms using immunoblot analysis. Almost all of these mutants show reduced number of isoforms, but are not like the p.S50 mutant with a single major protein isoform (A.K., J.S.F., A.S., unpublished data). Even after phosphatase treatment of the wild type protein, more than one NRL band is detected, suggesting additional posttranslational modifications. We propose that the phosphorylation at Ser-50 residue, probably modulated by Pro-51, plays an important role in triggering additional modifications in NRL.
Four other alterations (p.E63K, p.P67S, p.L75fs, and p.A76V) exist in or near NRL's MTD. The categorization of p.E63K and p.A76V is difficult. p.E63K's lower transactivation and p.A76V's decreased binding in EMSAs are consistent with the suggestion that these changes are recessive in nature. The p.E63K variation significantly changes amino acid polarity, which might have an effect on NRL-TBP or other protein-protein interactions, possibly causing reduced transcriptional function of NRL. The p.A76V, however, also activated the rhodopsin promoter at close to WT levels both in the presence and absence of CRX (this study; data not shown). Other studies have also shown transcription factor mutations having differential effects on DNA binding and transactivation [Chen et al., 2002; Lines et al., 2002] . It is possible FIGURE 5. Transactivation of the bovine rhodopsin promoter with WTor mutant NRL cDNA together with CRX. A^D: Di¡erent concentrations of WT or mutant NRL expression constructs (0.01^0.3 mg) were cotransfected into HEK293 cells with bovine rhodopsin À130 to 172-luciferase fusion construct (pGL2-pBR130) and CRX expression construct (pcDNA4-CRX). Fold change is relative to the empty expression vector control. Error bars indicate the standard error (SE).WT is indicated by a dark blue dotted line. Mutations were grouped based on, higher (A), similar (B), somewhat lower (C), and substantially lower (D) activity relative toWT NRL. Groups were assigned in part by the number of times the alterations were statistically di¡erent fromWT NRL. [Color ¢gure can be viewed in the online issue, which is available at www.interscience. wiley.com.] that the substitution of alanine with valine at position 76 affects NRL's conformation, which, in turn, differentially alters DNAbinding and transactivation. Our data shows p.P67S with similar transactivation as WT, indicating that it may not be a clinicallyrelevant variation. The p.L75fs mutation does not produce a stable, mature protein and has been previously suggested as disease causing when present with another loss of function NRL allele [Nishiguchi et al., 2004] .
Within NRL's hinge region, the p.G122E alteration was suggested to be a change of uncertain significance, while p.H125Q was considered a variation [Martinez-Gimeno et al., 2001] . Our current findings do not support the hypothesis that the p.G122E alteration is disease-causing. The p.G122E and p.H125Q alterations were not transcriptionally different from WT when tested with CRX and had an inconsistent pattern; nevertheless, these two showed high activity with the rhodopsin promoter when combined with both CRX and NR2E3. Although these alterations had measurable differences from WT in our assays, we still consider these particular changes to be of uncertain significance. Notably, both p.G122E and p.H125Q exist in the dog and frog orthologs of NRL, respectively. Additional studies are needed to clarify their importance. Maf's hinge domain is believed to modify the conformation of its N-terminal region and affect accessibility to general transcription factors [Yoshida and Yasuda, 2002] . It is possible that NRL's hinge region also behaves in a similar manner.
The remaining alterations are observed within the basic leucine zipper domain. The p.L160P and p.L160fs are near the DNAbinding basic domain and adjacent to NRL's ancillary DNAbinding region [Kerppola and Curran, 1994] . Both mutations have a remarkably negative impact on NRL function. We suggest that these variants function as recessive alleles and affect the recognition of NRL's DNA binding site. Furthermore, it is interesting that the p.L160P mutant isoforms migrated more slowly than WT though only a leucine to proline substitution is present. It is possible that this mutation introduces an as yet unknown posttranslational modification, which slows its migration in SDS-PAGE. Reduced DNA binding and transactivation by p.R218fs and p.S225N mutants show that these may be loss of function alleles. In the case of p.L235F, the reduction of luciferase activity occurred in only two of the four concentrations tested, suggesting that it may not be disease-causing.
To investigate the effect of heterozygote loss of functional alleles, we performed luciferase assays with cotransfections of WT and mutant NRL constructs. Although we tested WT with several NRL mutants (p.S50T, p.P51S, p.E63K, p.A76V, p.G122E, and p.L160P) at various DNA amounts using the rhodopsin promoter, we did not observe significant changes in transcriptional activity except with p.L160P (data not shown). Hence, we do not believe that NRL heterozygote loss of function alleles can cause disease, and that loss of function of both NRL alleles (e.g. p.L75fs/ p.L160P) is required, consistent with previous clinical findings [Nishiguchi et al., 2004] . Similarly, homozygous loss-of-function mutations in NR2E3 cause enhanced S-cone syndrome/ARRP [Gerber et al., 2000; Haider et al., 2000] . It is possible that heterozygotes with mutations in NRL are present in RP patients with digenic diallelic or digenic triallelic inheritance pattern. This kind of inheritance has been observed in other forms of RP [Kajiwara et al., 1994; Katsanis et al., 2001] . However, this would likely be a rare event and further work is required to test this hypothesis.
The morphogenesis and function of photoreceptors appear to be under strict genetic control since mutations in a large number of genes can lead to retinal and macular dystrophies. In animal models, both over-and underexpression of rhodopsin have been shown to cause photoreceptor cell death [Humphries et al., 1997; Tan et al., 2001] . Given that NRL plays a key role in rod photoreceptor development and maintenance, its activity must be controlled stringently. Control of NRL activity may provide a useful means to modulate its function by signaling molecules. We propose that phosphorylation and possibly other posttranslational modifications mediate NRL's interaction with other transcription regulatory proteins, and this in turn affects the nature of transcriptional complexes and target genes during photoreceptor development and in mature rods. 
